+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioprosthetics Market - Global Forecast 2026-2032- Product Image
Bioprosthetics Market - Global Forecast 2026-2032- Product Image
Sale

Bioprosthetics Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • July 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083827
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioprosthetics Market is projected to reach USD 6.37 Billion in 2026. It is expected to continue growing at a CAGR of 7.17%, reaching USD 9.81 Billion by 2032.

Bioprosthetics are biologically derived or biologically integrated medical implants used to restore, replace, or support damaged tissues and organs, with major applications across cardiovascular valves, vascular grafts, orthopedic reconstruction, soft-tissue repair, and advanced wound and reconstructive procedures. The field is gaining strategic importance as healthcare systems respond to population aging, higher prevalence of degenerative valve disease, rising musculoskeletal injury burden, and growing demand for implants that support improved biocompatibility and functional recovery. Compared with purely synthetic devices, bioprosthetic solutions are designed to reduce thrombogenicity, promote tissue integration, and offer clinically meaningful options for patients who may not be ideal candidates for long-term anticoagulation or conventional reconstructive approaches. Regulatory scrutiny, evidence generation, sterilization standards, tissue sourcing ethics, and long-term durability remain central to adoption. The bioprosthetics landscape is therefore shaped by a balance of clinical need, biomaterial innovation, surgical workflow compatibility, payer expectations, and post-market safety surveillance.

Transformative Shifts in the Bioprosthetics Landscape

The bioprosthetics sector is undergoing a structural shift from conventional replacement products toward biologically active, patient-centered implant strategies. In cardiovascular care, minimally invasive procedures and transcatheter delivery have expanded the clinical relevance of tissue-based valves, especially among older or high-risk patients. In orthopedics and soft-tissue repair, extracellular matrix scaffolds, decellularized tissues, and hybrid biomaterials are being refined to enhance remodeling, reduce inflammatory response, and support mechanical performance. Manufacturing is also evolving through improved tissue preservation, anti-calcification processing, terminal sterilization validation, and more rigorous lot-to-lot quality controls. Another major shift is the integration of imaging, computational modeling, and digital surgical planning to match implant selection with patient anatomy. At the same time, hospitals and procurement bodies are intensifying review of lifecycle value, complication reduction, revision risk, and real-world outcomes. These changes are moving bioprosthetics from a product-led category into an outcomes-driven platform for regenerative and reconstructive medicine.

Cumulative Impact of Artificial Intelligence on Bioprosthetics

Artificial intelligence is beginning to reshape bioprosthetics across research, design, manufacturing, clinical decision support, and post-market monitoring. In discovery and engineering, machine learning can help analyze biomaterial behavior, tissue microstructure, calcification risk factors, and biomechanical performance under simulated physiologic conditions. In clinical settings, AI-enabled imaging analysis may support more precise sizing of bioprosthetic heart valves, assessment of annular anatomy, prediction of procedural complications, and planning for valve-in-valve or revision procedures. Natural language processing and advanced analytics can also extract safety signals from electronic health records, registries, adverse-event reports, and longitudinal follow-up datasets. For manufacturers and clinical teams, AI-driven quality inspection, process monitoring, and predictive maintenance can strengthen reproducibility in complex biologic manufacturing environments. However, AI use in bioprosthetics requires explainability, validation across diverse populations, cybersecurity safeguards, and careful alignment with medical device regulatory expectations. The cumulative impact is expected to be strongest where AI improves patient selection, device durability assessment, and evidence-based clinical workflows without replacing physician judgment.

Key Regional Insights for Bioprosthetics

Asia-Pacific is becoming increasingly important for bioprosthetics due to rapid healthcare infrastructure expansion, aging populations in Japan, South Korea, China, and Australia, and rising access to advanced cardiovascular and orthopedic procedures. Demand is also supported by growing clinical capacity for minimally invasive interventions and government attention to domestic medical technology capabilities. North America remains a mature adoption environment, supported by established specialty hospitals, structured reimbursement pathways, large clinical trial activity, device registries, and high procedural volumes for cardiovascular and orthopedic care. Latin America is progressing unevenly, with Brazil and Mexico acting as key access points for advanced implant procedures while cost sensitivity, reimbursement variability, and specialist availability continue to influence uptake. Europe benefits from strong regulatory harmonization, health technology assessment processes, clinical guideline adoption, and advanced cardiac and reconstructive surgery networks, although procurement pressure and evidence requirements can lengthen commercialization timelines. The Middle East is expanding access through tertiary care investment, medical tourism strategies, and specialist centers, particularly in Gulf economies, while Africa shows growing need for reconstructive and cardiovascular solutions but faces constraints related to infrastructure, affordability, trained workforce availability, and supply chain reliability. Across all regions, adoption is closely tied to clinical evidence, implant durability, procedural expertise, reimbursement clarity, and the ability to maintain safe tissue handling and traceability standards.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN presents a diverse bioprosthetics environment in which Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines differ significantly in hospital infrastructure, reimbursement mechanisms, and access to specialist surgery. Growth in tertiary care and cross-border medical services supports adoption, but affordability and supply continuity remain decisive. GCC countries are investing in advanced tertiary hospitals, cardiac centers, and orthopedic specialty care, creating demand for high-quality bioprosthetic valves, grafts, and reconstructive materials supported by international clinical standards. The European Union provides one of the most structured regulatory and clinical evidence environments for bioprosthetics, with the Medical Device Regulation increasing emphasis on clinical evaluation, post-market surveillance, and traceability for implantable products. BRICS countries represent large and clinically diverse healthcare markets where population scale, chronic disease burden, and domestic manufacturing priorities are significant, though access varies widely between urban specialty centers and underserved regions. G7 countries generally show high adoption capacity due to advanced healthcare systems, strong academic medicine networks, and established reimbursement assessment, while NATO member states overlap substantially with advanced European and North American systems where resilient medical supply chains and standardized procurement have gained policy relevance. Across these groups, the strategic themes are evidence generation, regulatory compliance, biologic material traceability, skilled procedural training, and equitable patient access.

Key Country Insights for Bioprosthetics Adoption

The United States is a leading clinical and regulatory environment for bioprosthetics, supported by advanced cardiac surgery, transcatheter valve programs, orthopedic reconstruction, hospital registries, and high expectations for safety and real-world evidence. Canada emphasizes publicly funded access, evidence-based reimbursement, and specialist referral networks, while Mexico combines expanding private-sector advanced care with public-system access limitations. Brazil is Latin America’s major center for complex cardiovascular and reconstructive procedures, with clinical expertise concentrated in large urban hospitals. The United Kingdom relies on guideline-led adoption, health technology evaluation, and established cardiac and orthopedic services. Germany combines high procedural capacity, engineering expertise, and rigorous hospital purchasing standards, while France emphasizes regulated reimbursement and clinical evaluation. Russia has demand across cardiovascular and reconstructive care, though regional access and supply chain factors can affect availability. Italy and Spain maintain strong surgical capabilities and public healthcare systems but face procurement and budget pressures that influence product selection. China is rapidly expanding domestic medical technology capacity, specialist hospital networks, and access to advanced cardiac and orthopedic interventions. India has strong demand driven by population scale, cardiovascular disease burden, trauma care, and private tertiary hospitals, while affordability and reimbursement variation shape adoption. Japan’s aging population and advanced hospital system support use of bioprosthetic solutions, particularly in cardiovascular and orthopedic applications. Australia benefits from structured reimbursement, specialist care networks, and strong clinical governance. South Korea combines advanced hospital infrastructure, digital health capability, and medical technology innovation, supporting adoption where clinical evidence and reimbursement alignment are clear.

Actionable Recommendations for Bioprosthetics Industry Leaders

Industry leaders should prioritize clinically validated differentiation rather than product proliferation. Investment should focus on durability, anti-calcification performance, biocompatibility, infection resistance, handling characteristics, and compatibility with minimally invasive procedures. Robust clinical evidence strategies should include diverse patient populations, long-term follow-up, registry participation, and real-world performance monitoring. Organizations should strengthen tissue sourcing governance, donor screening compliance, sterilization validation, cold-chain or controlled logistics where required, and end-to-end traceability. Commercial teams should align value propositions with hospital priorities, including reduced complications, shorter procedure time, lower revision burden, and improved patient quality of life. Training programs for surgeons, interventional specialists, nurses, and procurement stakeholders are essential to reduce variability in outcomes. Leaders should also prepare for increasing regulatory demands by building proactive post-market surveillance systems, digital quality management, and AI governance frameworks where advanced analytics are used. Regionally tailored access strategies are critical, especially in markets with mixed public-private reimbursement, import dependencies, or limited specialist capacity.

Research Methodology

This executive summary is developed through a structured secondary research approach using verified and publicly accessible sources, including regulatory guidance, clinical practice guidelines, peer-reviewed biomedical literature, public health datasets, implant safety communications, hospital procedure trends, and policy documents relevant to biologic implants and medical devices. The analysis emphasizes evidence-backed themes across clinical adoption, regulatory requirements, biomaterial innovation, regional healthcare infrastructure, reimbursement dynamics, and post-market surveillance. Information is triangulated across multiple source types to reduce bias and ensure consistency, with priority given to authoritative medical, regulatory, and scientific references. The methodology excludes market sizing, market estimation, market share analysis, and forecasting. Qualitative insights are organized by region, economic group, and country to reflect differences in healthcare access, clinical capacity, regulatory maturity, and adoption readiness for bioprosthetic technologies.

Conclusion

Bioprosthetics are positioned at the intersection of regenerative medicine, implantable medical devices, and precision surgical care. Adoption is being shaped by aging demographics, cardiovascular and orthopedic disease burden, demand for minimally invasive procedures, and rising expectations for durable, biocompatible, and evidence-supported implants. The most important opportunities lie in improving long-term performance, strengthening clinical data, expanding training, and aligning products with real-world healthcare delivery constraints. Artificial intelligence, advanced imaging, improved biomaterial processing, and stronger post-market surveillance are creating a more data-driven environment for bioprosthetic innovation. Success will depend on the ability to combine scientific rigor, regulatory discipline, ethical tissue management, and region-specific access strategies. Organizations that demonstrate measurable clinical value, operational reliability, and transparent safety performance will be best positioned in the evolving global bioprosthetics landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bioprosthetics Market, by Product Type
7.1. Introduction
7.2. Bioprosthetic Heart Valves
7.2.1. Aortic Valve
7.2.2. Mitral Valve
7.2.3. Tricuspid Valve
7.2.4. Pulmonary Valve
7.3. Vascular Grafts
7.3.1. Coronary Artery Bypass Grafts
7.3.2. Peripheral Vascular Grafts
7.4. Soft Tissue Bioprosthetics
7.5. Orthopedic Bioprosthetics
7.6. Dental Bioprosthetics
7.7. Wound Care Bioprosthetics
7.8. Ophthalmic Bioprosthetics
8. Bioprosthetics Market, by Material Source
8.1. Introduction
8.2. Bovine Derived
8.3. Porcine Derived
8.4. Equine Derived
8.5. Human Tissue Derived
8.5.1. Autograft
8.5.2. Allograft
8.6. Marine Derived Biomaterials
9. Bioprosthetics Market, by Technology
9.1. Introduction
9.2. Decellularized Tissue Technology
9.3. Cross Linked Tissue Technology
9.4. Non Cross Linked Tissue processing
9.5. Electrospinning Based scaffolds
9.6. Hydrogel Based systems
10. Bioprosthetics Market, by Age Group
10.1. Introduction
10.2. Pediatric
10.3. Adult
10.4. Geriatric
11. Bioprosthetics Market, by Application Area
11.1. Introduction
11.2. Cardiovascular Applications
11.2.1. Valvular Heart Disease
11.2.2. Coronary Artery Disease
11.2.3. Peripheral Artery Disease
11.2.4. Congenital Heart Defects
11.3. Orthopedic Applications
11.3.1. Sports Injuries
11.3.2. Trauma & Fracture Management
11.3.3. Degenerative Joint Disease
11.4. Dental Applications
11.4.1. Tooth Replacement
11.4.2. Periodontal Defects
11.5. Plastic & Reconstructive Applications
11.5.1. Breast Reconstruction
11.5.2. Hernia Repair
11.5.3. Burn & Wound Management
11.6. Neurological Applications
11.6.1. Spinal Cord Repair
11.6.2. Peripheral Nerve Repair
11.7. Urologic & Pelvic Floor Applications
11.7.1. Urinary Incontinence
11.7.2. Pelvic Organ Prolapse
11.8. Ophthalmic Applications
12. Bioprosthetics Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Hospitals
12.3.1. Private Hospitals
12.3.2. Public Hospitals
12.4. Specialty Clinics
12.5. Rehabilitation centers
12.6. Academic & Research Institutes
13. Bioprosthetics Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Bioprosthetics Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Bioprosthetics Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Artivion Inc
17.3. Beijing Balance Medical Technology Co Ltd
17.4. Boston Scientific Corporation
17.5. Braile Biomédica
17.6. Colibri Heart Valve LLC
17.7. CONMED Corporation
17.8. Corcym S.r.l
17.9. Edwards Lifesciences Corporation
17.10. Foldax Inc
17.11. Getinge AB
17.12. Humacyte Inc
17.13. Integra LifeSciences Holdings Corporation
17.14. JenaValve Technology Inc
17.15. Labcor Laboratorios Ltda
17.16. LeMaitre Vascular Inc
17.17. LifeNet Health Inc
17.18. LivaNova PLC
17.19. Medtronic plc
17.20. Meril Life Sciences Pvt Ltd
17.21. MicroPort Scientific Corporation
17.22. Organogenesis Inc
17.23. Stryker Corporation
17.24. Tissue Regenix Group plc
17.25. TTK Healthcare Limited
17.26. Venus Medtech Hangzhou Inc
17.27. W. L. Gore & Associates
17.28. Zimmer Biomet Holdings Inc
List of Figures
FIGURE 1. GLOBAL BIOPROSTHETICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BIOPROSTHETICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BIOPROSTHETICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BIOPROSTHETICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BIOPROSTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOPROSTHETICS MARKET SIZE, BY MATERIAL SOURCE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BIOPROSTHETICS MARKET SIZE, BY MATERIAL SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION AREA, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BIOPROSTHETICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BIOPROSTHETICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BIOPROSTHETICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BIOPROSTHETICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BIOPROSTHETICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BIOPROSTHETICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL BIOPROSTHETICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL BIOPROSTHETICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BIOPROSTHETICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BIOPROSTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIOPROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIOPROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIOPROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL AORTIC VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL AORTIC VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL AORTIC VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MITRAL VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MITRAL VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MITRAL VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL TRICUSPID VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL TRICUSPID VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL TRICUSPID VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PULMONARY VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PULMONARY VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PERIPHERAL VASCULAR GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PERIPHERAL VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PERIPHERAL VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SOFT TISSUE BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SOFT TISSUE BIOPROSTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SOFT TISSUE BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ORTHOPEDIC BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ORTHOPEDIC BIOPROSTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ORTHOPEDIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DENTAL BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DENTAL BIOPROSTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DENTAL BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL WOUND CARE BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL WOUND CARE BIOPROSTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL WOUND CARE BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL OPHTHALMIC BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL OPHTHALMIC BIOPROSTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL OPHTHALMIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIOPROSTHETICS MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BOVINE DERIVED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BOVINE DERIVED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BOVINE DERIVED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PORCINE DERIVED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PORCINE DERIVED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PORCINE DERIVED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL EQUINE DERIVED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL EQUINE DERIVED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL EQUINE DERIVED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HUMAN TISSUE DERIVED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HUMAN TISSUE DERIVED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HUMAN TISSUE DERIVED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL AUTOGRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AUTOGRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AUTOGRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ALLOGRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ALLOGRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ALLOGRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MARINE DERIVED BIOMATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MARINE DERIVED BIOMATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MARINE DERIVED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DECELLULARIZED TISSUE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DECELLULARIZED TISSUE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DECELLULARIZED TISSUE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CROSS LINKED TISSUE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CROSS LINKED TISSUE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CROSS LINKED TISSUE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NON CROSS LINKED TISSUE PROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NON CROSS LINKED TISSUE PROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NON CROSS LINKED TISSUE PROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ELECTROSPINNING BASED SCAFFOLDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ELECTROSPINNING BASED SCAFFOLDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ELECTROSPINNING BASED SCAFFOLDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HYDROGEL BASED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HYDROGEL BASED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HYDROGEL BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CARDIOVASCULAR APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CARDIOVASCULAR APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CARDIOVASCULAR APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PERIPHERAL ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PERIPHERAL ARTERY DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PERIPHERAL ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CONGENITAL HEART DEFECTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CONGENITAL HEART DEFECTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL CONGENITAL HEART DEFECTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ORTHOPEDIC APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ORTHOPEDIC APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ORTHOPEDIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL SPORTS INJURIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL SPORTS INJURIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL SPORTS INJURIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL TRAUMA & FRACTURE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL TRAUMA & FRACTURE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL TRAUMA & FRACTURE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL DEGENERATIVE JOINT DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL DEGENERATIVE JOINT DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL DEGENERATIVE JOINT DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL DENTAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL DENTAL APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL DENTAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL TOOTH REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL TOOTH REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL TOOTH REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL PERIODONTAL DEFECTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL PERIODONTAL DEFECTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL PERIODONTAL DEFECTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL PLASTIC & RECONSTRUCTIVE APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL PLASTIC & RECONSTRUCTIVE APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL PLASTIC & RECONSTRUCTIVE APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL BREAST RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL HERNIA REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL HERNIA REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL BURN & WOUND MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL BURN & WOUND MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL BURN & WOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL NEUROLOGICAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL NEUROLOGICAL APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL NEUROLOGICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL SPINAL CORD REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL SPINAL CORD REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL SPINAL CORD REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL PERIPHERAL NERVE REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL PERIPHERAL NERVE REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL PERIPHERAL NERVE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL UROLOGIC & PELVIC FLOOR APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL UROLOGIC & PELVIC FLOOR APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL UROLOGIC & PELVIC FLOOR APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL URINARY INCONTINENCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL URINARY INCONTINENCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL URINARY INCONTINENCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL PELVIC ORGAN PROLAPSE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL PELVIC ORGAN PROLAPSE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL PELVIC ORGAN PROLAPSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL OPHTHALMIC APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL OPHTHALMIC APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL OPHTHALMIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY BIOPROSTHETIC HEART VALVES, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY HUMAN TISSUE DERIVED, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY UROLOGIC & PELVIC FLOOR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 201. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 202. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 203. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY BIOPROSTHETIC HEART VALVES, 2018-2032 (USD MILLION)
TABLE 204. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 205. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
TABLE 206. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY HUMAN TISSUE DERIVED, 2018-2032 (USD MILLION)
TABLE 207. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 208. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 209. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 210. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 211. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 212. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 213. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 214. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 215. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY UROLOGIC & PELVIC FLOOR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 216. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. NORTH AMERICA BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 218. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 219. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 220. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY BIOPROSTHETIC HEART VALVES, 2018-2032 (USD MILLION)
TABLE 221. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 222. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
TABLE 223. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY HUMAN TISSUE DERIVED, 2018-2032 (USD MILLION)
TABLE 224. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 225. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 226. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 227. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 228. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 229. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 230. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 231. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 232. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY UROLOGIC & PELVIC FLOOR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 233. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. LATIN AMERICA BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 235. EUROPE BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 236. EUROPE BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. EUROPE BIOPROSTHETICS MARKET SIZE, BY BIOPROSTHETIC HEART VALVES, 2018-2032 (USD MILLION)
TABLE 238. EUROPE BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 239. EUROPE BIOPROSTHETICS MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
TABLE 240. EUROPE BIOPROSTHETICS MARKET SIZE, BY HUMAN TISSUE DERIVED, 2018-2032 (USD MILLION)
TABLE 241. EUROPE BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 242. EUROPE BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 243. EUROPE BIOPROSTHETICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 244. EUROPE BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 245. EUROPE BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 246. EUROPE BIOPROSTHETICS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 247. EUROPE BIOPROSTHETICS MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 248. EUROPE BIOPROSTHETICS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 249. EUROPE BIOPROSTHETICS MARKET SIZE, BY UROLOGIC & PELVIC FLOOR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 250. EUROPE BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 251. EUROPE BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 252. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 253. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 254. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY BIOPROSTHETIC HEART VALVES, 2018-2032 (USD MILLION)
TABLE 255. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 256. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
TABLE 257. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY HUMAN TISSUE DERIVED, 2018-2032 (USD MILLION)
TABLE 258. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 259. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 260. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 261. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 262. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 263. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 264. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 265. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 266. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY UROLOGIC & PELVIC FLOOR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 267. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 268. MIDDLE EAST BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 269. AFRICA BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 270. AFRICA BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 271. AFRICA BIOPROSTHETICS MARKET SIZE, BY BIOPROSTHETIC HEART VALVES, 2018-2032 (USD MILLION)
TABLE 272. AFRICA BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 273. AFRICA BIOPROSTHETICS MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
TABLE 274. AFRICA BIOPROSTHETICS MARKET SIZE, BY HUMAN TISSUE DERIVED, 2018-2032 (USD MILLION)
TABLE 275. AFRICA BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 276. AFRICA BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 277. AFRICA BIOPROSTHETICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 278. AFRICA BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 279. AFRICA BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 280. AFRICA BIOPROSTHETICS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 281. AFRICA BIOPROSTHETICS MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 282. AFRICA BIOPROSTHETICS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 283. AFRICA BIOPROSTHETICS MARKET SIZE, BY UROLOGIC & PELVIC FLOOR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 284. AFRICA BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 285. AFRICA BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 286. GLOBAL BIOPROSTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 287. ASEAN BIOPROSTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 288. ASEAN BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 289. ASEAN BIOPROSTHETICS MARKET SIZE, BY BIOPROSTHETIC HEART VALVES, 2018-2032 (USD MILLION)
TABLE 290. ASEAN BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 291. ASEAN BIOPROSTHETICS MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
TABLE 292. ASEAN BIOPROSTHETICS MARKET SIZE, BY HUMAN TISSUE DERIVED, 2018-2032 (USD MILLION)
TABLE 293. ASEAN BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 294. ASEAN BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 295. ASEAN BIOPROSTHETICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 296. ASEAN BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 297. ASEAN BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 298. ASEAN BIOPROSTHETICS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 299. ASEAN BIOPROSTHETICS MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 300. ASEAN BIOPROSTHETICS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 301. ASEAN BIOPROSTHETICS MARKET SIZE, BY UROLOGIC & PELVIC FLOOR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 302. ASEAN BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 303. ASEAN BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 304. GCC BIOPROSTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 305. GCC BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 306. GCC BIOPROSTHETICS MARKET SIZE, BY BIOPROSTHETIC HEART VALVES, 2018-2032 (USD MILLION)
TABLE 307. GCC BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 308. GCC BIOPROSTHETICS MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
TABLE 309. GCC BIOPROSTHETICS MARKET SIZE, BY HUMAN TISSUE DERIVED, 2018-2032 (USD MILLION)
TABLE 310. GCC BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 311. GCC BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 312. GCC BIOPROSTHETICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 313. GCC BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 314. GCC BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 315. GCC BIOPROSTHETICS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 316. GCC BIOPROSTHETICS MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 317. GCC BIOPROSTHETICS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 318. GCC BIOPROSTHETICS MARKET SIZE, BY UROLOGIC & PELVIC FLOOR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 319. GCC BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 320. GCC BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 321. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 322. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 323. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY BIOPROSTHETIC HEART VALVES, 2018-2032 (USD MILLION)
TABLE 324. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 325. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
TABLE 326. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY HUMAN TISSUE DERIVED, 2018-2032 (USD MILLION)
TABLE 327. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 328. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 329. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 330. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 331. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 332. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 333. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 334. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 335. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY UROLOGIC & PELVIC FLOOR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 336. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 337. EUROPEAN UNION BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 338. BRICS BIOPROSTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 339. BRICS BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 340. BRICS BIOPROSTHETICS MARKET SIZE, BY BIOPROSTHETIC HEART VALVES, 2018-2032 (USD MILLION)
TABLE 341. BRICS BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 342. BRICS BIOPROSTHETICS MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
TABLE 343. BRICS BIOPROSTHETICS MARKET SIZE, BY HUMAN TISSUE DERIVED, 2018-2032 (USD MILLION)
TABLE 344. BRICS BIOPROSTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 345. BRICS BIOPROSTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 346. BRICS BIOPROSTHETICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 347. BRICS BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 348. BRICS BIOPROSTHETICS MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 349. BRICS BIOPROSTHETICS MARKET SIZE, BY DENTAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 350. BRICS BIOPROSTHETICS MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 351. BRICS BIOPROSTHETICS MARKET SIZE, BY NEUROLOGICAL APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 352. BRICS BIOPROSTHETICS MARKET SIZE, BY UROLOGIC & PELVIC FLOOR APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 353. BRICS BIOPROSTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 354. BRICS BIOPROSTHETICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 355. G7 BIOPROSTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 356. G7 BIOPROSTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 357. G7 BIOPROSTHETICS MARKET SIZE, BY BIOPROSTHETIC HEART VALVES, 2018-2032 (USD MILLION)
TABLE 358. G7 BIOPROSTHETICS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 359. G7 BIOPROSTHETICS MARKET SIZE, BY MATERIA

Companies Mentioned

  • Abbott Laboratories
  • Artivion Inc
  • Beijing Balance Medical Technology Co Ltd
  • Boston Scientific Corporation
  • Braile Biomédica
  • Colibri Heart Valve LLC
  • CONMED Corporation
  • Corcym S.r.l
  • Edwards Lifesciences Corporation
  • Foldax Inc
  • Getinge AB
  • Humacyte Inc
  • Integra LifeSciences Holdings Corporation
  • JenaValve Technology Inc
  • Labcor Laboratorios Ltda
  • LeMaitre Vascular Inc
  • LifeNet Health Inc
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt Ltd
  • MicroPort Scientific Corporation
  • Organogenesis Inc
  • Stryker Corporation
  • Tissue Regenix Group plc
  • TTK Healthcare Limited
  • Venus Medtech Hangzhou Inc
  • W. L. Gore & Associates
  • Zimmer Biomet Holdings Inc

Table Information

Report AttributeDetails
No. of Pages182
PublishedJuly 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.37 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.81 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Bioprosthetics - Global Strategic Business Report - Product Image

Bioprosthetics - Global Strategic Business Report

  • Report
  • 267 Pages
  • Global
From
Bioprosthetics Market Report 2026 - Product Image

Bioprosthetics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Bioprosthetic Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Bioprosthetic Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Artificial Implants Market - Global Forecast 2026-2032 - Product Image

Artificial Implants Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Endoprosthesis Market - Global Forecast 2026-2032 - Product Image

Endoprosthesis Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From

About the Market

The bioprosthetic market within the context of orthopedic devices is a rapidly growing sector of the medical device industry. Bioprosthetics are artificial implants made from biological materials, such as collagen, that are designed to replace or repair damaged or diseased tissue. These implants are used in a variety of orthopedic procedures, including joint replacement, spinal fusion, and fracture repair. Bioprosthetics offer a number of advantages over traditional implants, including improved durability, flexibility, and biocompatibility. Bioprosthetics are becoming increasingly popular in the orthopedic device market due to their ability to provide a more natural feel and improved patient outcomes. As a result, many companies are investing in the development of new bioprosthetic products and technologies. Some of the leading companies in the bioprosthetic market include Zimmer Biomet, Stryker, Smith & Nephew, and Medtronic. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.